Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 149

    Narcotics Control Bureau seals illegal Ketamine factory in Hyderabad

    Narcotics Control Bureau seals illegal Ketamine factory in Hyderabad

    Medical Dialogues Bureau4 May 2019 9:30 AM IST
    This came a day after the NCB arrested a Bengaluru native for producing Ketamine, a medication mainly used for starting and maintaining...
    Gilead Sciences posts higher Q1 profit; drug sales in line with expectations

    Gilead Sciences posts higher Q1 profit; drug sales in line with expectations

    Garima4 May 2019 9:00 AM IST
    Gilead Sciences said it still expects relatively flat full-year 2019 product sales of $21.3 billion to $21.8 billion.U.S: Gilead Sciences Inc on...
    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Meghna A Singhania3 May 2019 1:50 PM IST
    Mumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
    Pharma Ex Chairman held guilty of bribing doctors in millions to push opioid

    Pharma Ex Chairman held guilty of bribing doctors in millions to push opioid

    Medical Dialogues Bureau3 May 2019 10:05 AM IST
    The 76-year-old former chairman of Insys Therapeutics was found guilty of racketeering conspiracy after 15 days of jury deliberations.BOSTON: A...
    Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement with Otonomy

    Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement with Otonomy

    Farhat Nasim3 May 2019 10:00 AM IST
    OTIPRIO is a sterile, preservative-free, otic suspension of 6% ciprofloxacin administered as a single-dose by a healthcare professional. Mumbai:...
    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Medical Dialogues Bureau3 May 2019 9:15 AM IST
    Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
    AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients

    AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients

    Farhat Nasim3 May 2019 9:10 AM IST
    New Delhi: AbbVie Inc. recently won the U.S. Food and Drug Administration (USFDA) approval for Mavyret (glecaprevir and pibrentasvir) tablets to treat...
    Merck Q1 net profit up as cancer drug, vaccine sales soar

    Merck Q1 net profit up as cancer drug, vaccine sales soar

    Garima3 May 2019 9:00 AM IST
    Gardasil, a vaccine for preventing cancers associated with human papillomavirus, powered much of the earnings beat, helped by higher vaccination rates...
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Farhat Nasim2 May 2019 4:04 PM IST
    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Farhat Nasim2 May 2019 10:00 AM IST
    Dengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
    AstraZeneca ties up with Transgene to develop viral immunotherapies

    AstraZeneca ties up with Transgene to develop viral immunotherapies

    Garima2 May 2019 9:25 AM IST
    AstraZeneca has been moving deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy.New...
    Novartis division strikes deal with Eir Genix to market biosimilar of Herceptin

    Novartis division strikes deal with Eir Genix to market biosimilar of Herceptin

    Medical Dialogues Bureau2 May 2019 9:15 AM IST
    EirGenix will be responsible for development and manufacturing, while Sandoz has the right to commercialize in all markets except China and Taiwan....
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok